School of Medical Sciences

Search results

• Molecular markers and drug development leading to improvements in radiotherapy.

  Stratford, I. (Participant), Williams, K. (Participant), West, C. (Participant), (Participant), (Participant), Eustace, A. (Participant) & (Participant)

  Impact: Health impacts

• New targeted therapies in Non-Small Cell Lung Cancer improve patient outcomes

  Blackhall, F. (Participant) & (Participant)

  Impact: Health and wellbeing, Economic

• NHS Voices of Covid-19: Impacts from our work in creating a national collection of personal testimonies about the significance of the Covid-19 pandemic

  Snow, S. (Corresponding participant) & Whitecross, A. (Participant)

  Impact: Awareness and understanding, Attitudes and behaviours, Policy

• NICE Prostate cancer: diagnosis and management clinical guideline [CG175]

  Hoskin, P. (Participant)

  Impact

• Non-Hodgkin’s lymphoma: diagnosis and management NICE guideline [NG52]

  Hoskin, P. (Participant)

  Impact: Health impacts

• Ongoing impacts of the development of an electrical stimulation treatment for dysphasia (Phagenyx by UoM Spinout Phagenesis)

  Hamdy, S. (Corresponding participant)

  Impact: Health and wellbeing, Economic

• Online tool (CORONET) created to support clinical decisions regarding hospital admissions or discharge in cancer patients presenting with symptoms of COVID-19 and the likely severity of illness

  Lee, R. (Corresponding participant), (Participant) & (Participant)

  Impact: Health and wellbeing

• Optimising patient care for the prevention of dental caries

  Glenny, A.-M. (Participant), Worthington, H. (Participant), Clarkson, J. (Participant) & Walsh, T. (Participant)

  Impact: Health and wellbeing, Society and culture, Attitudes and behaviours, Awareness and understanding

• Our research as part of the international PACIFIC trial, led to the approval of a new treatment (Durvalumab) which improves progression free and overall survival in Stage III Non-small cell lung cancer (NSCLC)

  Faivre-Finn, C. (Corresponding participant)

  Impact: Health and wellbeing

• Outcome of Men With Relapse After Adjuvant Carboplatin for Clinical Stage

  (Participant)

  Impact: Health impacts

• Panel member of the EAU guidelines for prostate cancer

  (Participant)

  Impact

• Placenta growth factor (PlGF) blood test for pre-eclampsia recommended by NICE then rolled out more widely by NHS England speeding up diagnosis and helping determine those most at risk

  Myers, J. (Corresponding participant), Ormesher, L. (Participant), Johnstone, E. (Participant) & Duhig, K. (Participant)

  Impact: Health and wellbeing, Economic

• Policy plan 2016-2020 for measuring quality in radiation oncology for the Dutch Society of Radiotherapy and Oncology.

  (Participant)

  Impact

• Preventing bone loss in patients treated for breast cancer

  Bundred, N. (Participant) & Howell, T. (Participant)

  Impact: Health impacts

• Preventing cardiovascular disease in rural Indonesia by using a smartphone app in a socio-medical intervention

  Tampubolon, G. (Participant) & Oceandy, D. (Participant)

  Impact

• Preventing Stillbirth and Improving the Quality of Care After a Baby Dies

  Heazell, A. (Participant), Jones, R. (Participant) & Sibley, C. (Participant)

  Impact: Health and wellbeing

• Producing innovative diagnostic software/products for the earlier identification of dental decay and other potential problems (Spin out company Manchester Imaging Ltd)

  Devlin, H. (Corresponding participant), Horner, K. (Participant) & Graham, J. (Participant)

  Impact: Health and wellbeing, Technological, Economic

• Promoting oral health in medically compromised patients to improve patient outcomes

  Glenny, A.-M. (Participant), Worthington, H. (Participant), Clarkson, J. (Participant), Riley, P. (Participant) & Mccabe, M. (Participant)

  Impact: Health and wellbeing

• Proton gap-analysis for lung cancer radiotherapy

  (Participant)

  Impact

• Publication of national evidence-based guidelines for the management of lymphoma

  (Participant)

  Impact: Economic impacts, Health impacts, Political impacts

• Radical reorganisation of trauma services reduces risk and saves many lives among severely injured patients

  (Participant), (Participant), Patel, H. (Participant), (Participant) & (Participant)

  Impact: Health and wellbeing

• Radiotherapy research changes standard clinical practice and improves survival for patients with small-cell lung cancer

  Faivre-Finn, C. (Corresponding participant), Blackhall, F. (Participant) & Lorigan, P. (Participant)

  Impact: Health and wellbeing

• Radiotherapy to the primary tumour for newly diagnosed, metastatic prostate cancer (STAMPEDE): a randomised controlled phase 3 trial

  (Corresponding participant)

  Impact: Health and wellbeing

• Radium-223 and concomitant therapies in patients with metastatic castration-resistant prostate cancer

  (Participant)

  Impact: Health impacts

• Raising awareness of non-colonic symptoms in irritable bowel syndrome to prevent incorrect referrals and unnecessary treatments

  Peter Whorwell (Participant)

  Impact: Health and wellbeing